Elevance Health Inc (ELV) stock saw a modest uptick, ending the day at $385.29 which represents a slight increase of $0.03 or 0.01% from the prior close of $385.26. The stock opened at $387.02 and ...

Morgan Stanley analyst Erin Wright maintained a Hold rating on Elevance Health (ELV – Research Report) today and set a price target of $388.00.

2023 Elevance Health Inc Registered Shs 5.92 1.26 USD 2022 Elevance Health Inc Registered Shs 5.12 1.00 USD 2021 Elevance Health Inc Registered Shs 4.52 0.98 USD 2020 Elevance Health Inc ...

Truist lowered the firm’s price target on Elevance Health (ELV) to $480 from $520 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The ...

Buying $100 In ELV: If an investor had bought $100 of ELV stock 20 years ago, it would be worth $647.66 today based on a ...

So it may not tell us anything about how insiders feel about the current share price. In the last year Elevance Health insiders didn't buy any company stock. You can see the insider transactions ...

Morgan Stanley dropped their target price on Elevance Health from $643.00 to $551.00 and set an “overweight” rating on the stock in a report on Wednesday, October 23rd. Cantor Fitzgerald ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TD Cowen lowered their target price on shares of Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research note on Monday, October 21st. Morgan Stanley cut ...

Investment management company Vulcan Value Partners recently released its fourth-quarter 2024 investor letter. A copy of the ...

View Elevance Health, Inc. (ELV) current and estimated P/E ratio data provided by Seeking Alpha.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.